Acceptable hearing and vision rehabilitation is needed to improve quality of life for people with dementia (PwD) living at home. We examined delivery and uptake of SENSE-Cog, a complex sensory support intervention (SSI), within a European multicentre randomised controlled trial.
The SENSE-Cog process analysis reveals that pandemic-related disruptions significantly affected sensory rehabilitation delivery for people with dementia; audiologists working in care settings should plan for remote or hybrid delivery models to maintain continuity when in-person access is restricted.
As the field moves toward integrating sensory rehabilitation into dementia care, understanding real-world delivery barriers — including pandemic-level disruptions — is essential for designing resilient, scalable hearing intervention programs.
- 01SENSE-Cog trial examined hearing and vision rehabilitation for people with dementia across multiple sites.
- 02COVID-19 pandemic substantially impacted the delivery and uptake of the intervention.
- 03Process evaluation ('under the hood' analysis) identifies implementation barriers and facilitators.
- 04Findings are relevant to designing robust sensory care pathways in dementia services.
- 05Results may inform future hybrid or remote delivery models for sensory rehabilitation.
The COVID-19 pandemic negatively impacted the delivery and uptake of the SENSE-Cog hearing and vision rehabilitation intervention for people with dementia.
studysupportedA combined hearing and vision support intervention can be delivered to people with dementia in a trial setting.
studypartially supported- PMID
- 42212629
- DOI
- 10.1080/09638288.2026.2676067.
- Journal
- Disability and Rehabilitation
- Publication type
- research_article
- Evidence level
- 1b
- Population
- People with dementia enrolled in the SENSE-Cog randomised trial requiring hearing and/or vision rehabilitation
- Intervention
- Hearing and vision sensory support rehabilitation intervention delivered within the SENSE-Cog trial
- Comparator
- Usual care or control arm within SENSE-Cog trial
Primary outcomes
Delivery fidelity and uptake of the hearing/vision intervention; Impact of COVID-19 pandemic on trial delivery and participation